Clinical pharmacology of vecuronium in children. Studies during nitrous oxide and halothane in oxygen anaesthesia. 1986

C Meistelman, and J P Loose, and C Saint-Maurice, and M M Delleur, and G L da Silva

Forty-seven children (ASA I or II) were studied during nitrous oxide-oxygen, halothane anaesthesia. The dose-response curve for vecuronium was determined after the injection of a single bolus (40, 55 or 70 micrograms kg-1) to 33 patients. The ED50 and ED95 were 31 and 64 micrograms kg-1 respectively. Fourteen children received a larger dose (100 micrograms kg-1); good intubating conditions were obtained in all of these within 2 min. After a single bolus (100 micrograms kg-1) the duration of action was 36.5 min and the recovery index was 9.3 min. In patients who received small maintenance doses (25 micrograms kg-1) after a single bolus (100 micrograms kg-1) the recovery index after the last maintenance dose was not increased. There were no significant changes in heart rate or arterial pressure. In children, vecuronium has a short duration of action and lacks cumulative or cardiovascular side affects.

UI MeSH Term Description Entries
D007442 Intubation, Intratracheal A procedure involving placement of a tube into the trachea through the mouth or nose in order to provide a patient with oxygen and anesthesia. Intubation, Endotracheal,Endotracheal Intubation,Endotracheal Intubations,Intratracheal Intubation,Intratracheal Intubations,Intubations, Endotracheal,Intubations, Intratracheal
D009119 Muscle Contraction A process leading to shortening and/or development of tension in muscle tissue. Muscle contraction occurs by a sliding filament mechanism whereby actin filaments slide inward among the myosin filaments. Inotropism,Muscular Contraction,Contraction, Muscle,Contraction, Muscular,Contractions, Muscle,Contractions, Muscular,Inotropisms,Muscle Contractions,Muscular Contractions
D009466 Neuromuscular Blocking Agents Drugs that interrupt transmission of nerve impulses at the skeletal neuromuscular junction. They can be of two types, competitive, stabilizing blockers (NEUROMUSCULAR NONDEPOLARIZING AGENTS) or noncompetitive, depolarizing agents (NEUROMUSCULAR DEPOLARIZING AGENTS). Both prevent acetylcholine from triggering the muscle contraction and they are used as anesthesia adjuvants, as relaxants during electroshock, in convulsive states, etc. Neuromuscular Blocker,Neuromuscular Blocking Agent,Neuromuscular Blockers,Agent, Neuromuscular Blocking,Agents, Neuromuscular Blocking,Blocker, Neuromuscular,Blockers, Neuromuscular,Blocking Agent, Neuromuscular,Blocking Agents, Neuromuscular
D009609 Nitrous Oxide Nitrogen oxide (N2O). A colorless, odorless gas that is used as an anesthetic and analgesic. High concentrations cause a narcotic effect and may replace oxygen, causing death by asphyxia. It is also used as a food aerosol in the preparation of whipping cream. Laughing Gas,Nitrogen Protoxide,Gas, Laughing,Oxide, Nitrous
D010100 Oxygen An element with atomic symbol O, atomic number 8, and atomic weight [15.99903; 15.99977]. It is the most abundant element on earth and essential for respiration. Dioxygen,Oxygen-16,Oxygen 16
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D002675 Child, Preschool A child between the ages of 2 and 5. Children, Preschool,Preschool Child,Preschool Children
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D006221 Halothane A nonflammable, halogenated, hydrocarbon anesthetic that provides relatively rapid induction with little or no excitement. Analgesia may not be adequate. NITROUS OXIDE is often given concomitantly. Because halothane may not produce sufficient muscle relaxation, supplemental neuromuscular blocking agents may be required. (From AMA Drug Evaluations Annual, 1994, p178) 1,1,1-Trifluoro-2-Chloro-2-Bromoethane,Fluothane,Ftorotan,Narcotan
D006439 Hemodynamics The movement and the forces involved in the movement of the blood through the CARDIOVASCULAR SYSTEM. Hemodynamic

Related Publications

C Meistelman, and J P Loose, and C Saint-Maurice, and M M Delleur, and G L da Silva
November 1994, British journal of anaesthesia,
C Meistelman, and J P Loose, and C Saint-Maurice, and M M Delleur, and G L da Silva
July 1991, Anesthesia and analgesia,
C Meistelman, and J P Loose, and C Saint-Maurice, and M M Delleur, and G L da Silva
February 1989, Anesthesia and analgesia,
C Meistelman, and J P Loose, and C Saint-Maurice, and M M Delleur, and G L da Silva
December 1982, Acta anaesthesiologica Scandinavica,
C Meistelman, and J P Loose, and C Saint-Maurice, and M M Delleur, and G L da Silva
November 1969, British journal of anaesthesia,
C Meistelman, and J P Loose, and C Saint-Maurice, and M M Delleur, and G L da Silva
December 1985, British journal of anaesthesia,
C Meistelman, and J P Loose, and C Saint-Maurice, and M M Delleur, and G L da Silva
January 1966, Anesthesia and analgesia,
C Meistelman, and J P Loose, and C Saint-Maurice, and M M Delleur, and G L da Silva
April 1988, Acta anaesthesiologica Scandinavica,
C Meistelman, and J P Loose, and C Saint-Maurice, and M M Delleur, and G L da Silva
January 1960, Acta anaesthesiologica Scandinavica,
C Meistelman, and J P Loose, and C Saint-Maurice, and M M Delleur, and G L da Silva
January 1998, Anaesthesia,
Copied contents to your clipboard!